{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:38:55Z","timestamp":1790253535072,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T00:00:00Z","timestamp":1485475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jcin.2017.01.022","type":"journal-article","created":{"date-parts":[[2017,4,17]],"date-time":"2017-04-17T16:01:29Z","timestamp":1492444889000},"page":"774-782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Economic Outcomes of Bioresorbable\u00a0Vascular Scaffolds Versus\u00a0Everolimus-Eluting Stents in Patients\u00a0Undergoing Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"10","author":[{"given":"Suzanne J.","family":"Baron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaja","family":"Chinnakondepalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Vilain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Magnuson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean J.","family":"Kereiakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2017.01.022_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijcard.2011.04.004","article-title":"Comparison of the safety between first- and second-generation drug eluting stents: meta-analysis from 19 randomized trials and 16,924 patients","volume":"160","author":"Martin-Reyes","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2017.01.022_bib2","doi-asserted-by":"crossref","first-page":"e000064","DOI":"10.1136\/openhrt-2014-000064","article-title":"First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patients","volume":"1","author":"Navarese","year":"2014","journal-title":"Open Heart"},{"key":"10.1016\/j.jcin.2017.01.022_bib3","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1161\/CIRCULATIONAHA.108.826479","article-title":"Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies","volume":"119","author":"Kirtane","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2017.01.022_bib4","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1161\/CIRCULATIONAHA.112.097014","article-title":"Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials","volume":"125","author":"Bangalore","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2017.01.022_bib5","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.jacc.2015.04.017","article-title":"Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"65","author":"Palmerini","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.01.022_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.01.022_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.113.001790","article-title":"Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans","volume":"129","author":"Otsuka","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2017.01.022_bib8","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2017.01.022_bib9","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1161\/01.CIR.92.9.2480","article-title":"In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators","volume":"92","author":"Cohen","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2017.01.022_bib10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/01.CIR.0000136821.99814.43","article-title":"Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial","volume":"110","author":"Cohen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2017.01.022_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jacc.2006.02.063","article-title":"Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial","volume":"48","author":"Bakhai","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.01.022_bib12","series-title":"100% MEDPAR inpatient hospital national data for fiscal year 2013: short stay inpatient diagnosis groups","year":"2013"},{"key":"10.1016\/j.jcin.2017.01.022_bib13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1067\/mhj.2003.3","article-title":"Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials","volume":"145","author":"Taira","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2017.01.022_bib14","first-page":"476","article-title":"The ratio of costs to charges: how good a basis for estimating costs?","volume":"32","author":"Shwartz","year":"1995","journal-title":"Inquiry"},{"key":"10.1016\/j.jcin.2017.01.022_bib15","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/CIRCULATIONAHA.112.147488","article-title":"Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial","volume":"127","author":"Magnuson","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2017.01.022_bib16","first-page":"198","article-title":"Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial","volume":"79","author":"Cohen","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2017.01.022_bib17","series-title":"National physician fee schedule relative value calendar year 2015","year":"2015"},{"key":"10.1016\/j.jcin.2017.01.022_bib18","series-title":"Per case prospective payment for episodes of hospital care","author":"Mitchell","year":"1995"},{"key":"10.1016\/j.jcin.2017.01.022_bib19","unstructured":"RED BOOK Online. Micromedex Healthcare Series [database online]. Ann Arbor, MI: Truven Health\u00a0Analytics; 2015. Available at: http:\/\/www.micromedexsolutions.com. Accessed June 11, 2015."},{"key":"10.1016\/j.jcin.2017.01.022_bib20","first-page":"984","article-title":"Does optimal lesion preparation reduce the amount of acute recoil of the Absorbe BVS? Insights from a real-world population","volume":"86","author":"Danzi","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2017.01.022_bib21","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jcin.2016.03.027","article-title":"The impact of post-procedural asymmetry, expansion, and eccentricity of bioresorbable everolimus-eluting scaffold and metallic everolimus-eluting stent on clinical outcomes in the ABSORB II trial","volume":"9","author":"Suwannasom","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2017.01.022_bib22","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(15)01039-9","article-title":"1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis","volume":"387","author":"Stone","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2017.01.022_bib23","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1253\/circj.CJ-11-1416","article-title":"Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segments","volume":"76","author":"Brugaletta","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.jcin.2017.01.022_bib24","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/eurheartj\/ehr466","volume":"33","author":"Brugaletta","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2017.01.022_bib25","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/S0140-6736(16)32050-5","article-title":"Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial","volume":"388","author":"Serruys","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2017.01.022_bib26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/CIRCOUTCOMES.110.960187","article-title":"Cost-effectiveness of drug-eluting stents versus bare metal stents in clinical practice","volume":"4","author":"Schafer","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jcin.2017.01.022_bib27","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jacc.2006.01.080","article-title":"Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease","volume":"48","author":"Elezi","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.01.022_bib28","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0735-1097(99)00267-3","article-title":"Multivariate prediction of in-hospital mortality after percutaneous coronary interventions in 1994-1996. Northern New England Cardiovascular Disease Study Group","volume":"34","author":"O'Connor","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.01.022_bib29","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jcin.2011.07.016","volume":"4","author":"Claessen","year":"2011","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2017.01.022_bib30","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.amjcard.2014.03.007","article-title":"Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction)","volume":"113","author":"Loh","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2017.01.022_bib31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.amjcard.2005.08.047","article-title":"Hospital resources consumed in treating complications associated with percutaneous coronary interventions","volume":"97","author":"Kugelmass","year":"2006","journal-title":"Am J Cardiol"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879817301978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879817301978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:04:49Z","timestamp":1761847489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879817301978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1936879817301978"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2017.01.022","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic Outcomes of Bioresorbable\u00a0Vascular Scaffolds Versus\u00a0Everolimus-Eluting Stents in Patients\u00a0Undergoing Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2017.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}